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Considerable attention has been given to the use of vesicular carriers of enzymes in the therapy of genetically inherited enzyme deficiencies and drugs in cancer chemotherapy. There are many difficulties inherent in such an approach, including the premature inactivation of the enzyme or drug in the plasma, failure to reach the target tissue or possible immunological reaction against a foreign enzyme. Liposomes (phospholipid vesicles) have been proposed as a potential carrier (Ryman, 1975) , and experimental models have shown their use in the therapy of artificially created storage conditions both in uitro (Gregoriadis & Buckland, 1973) and in vivo (Colley & Ryman, 1974) . Their use in cancer chemotherapy has also been demonstrated in tumour-bearing animals by Rahman et al. (1974) . In the present communication we discuss the entrapment of therapeutic agents in resealed erythrocyte 'ghosts' and follow their fate in viuo.
Enzymes or drugs were entrapped in erythrocytes by a method essentially similar to that of Ihler et al. (1973) . In short, erythrocytes were spun down from heparinized whole blood and washed several times in phosphate-buffered saline. Lysis of erythrocytes was carried out at 4°C for 1 min with 3 vol. of distilled water containing the substance to be entrapped. Resealing of the lysed 'ghosts' was achieved by the addition of the appropriate volume of 2M-NaCl to return the cells to iso-osmoticity and subsequent incubation at 37°C for 15min. Resealed cells were then washed several times with phosphate-buffered saline and assayed for radioactivity or enzyme activity after lysis. we have not investigated this to any great extent it seems reasonable to assume that the percentage entrapment will fall off as this concentration is raised. In these experiments, rat erythrocyte 'ghosts' were found most difficult to reseal successfully, whereas those from mouse and human erythrocytes seemed to reseal easily, and closely resemble the original cells when viewed under light microscopy. This difficulty with rat cells may be a function of the composition of the cell membrane. Certainly rat cells are very susceptible to glycerol haemolysis, suggesting their membrane is more fluid than the erythrocyte membranes of other species (O'Brien, 1697). The leakage of entrapped substances, including low-molecular-weight drugs such as methotrexate, has been found to be small after 1 h even at 37°C when the cells were resuspended in serum. The fate of resealed 'ghosts' in uiuo has been followed in two ways. The first involves the entrapment of the enzyme /3-fructofuranosidase, whose fate when administered in liposomes (Gregoriadis & Ryman, 1972) and when administered free (Jacques & Bruns, 1965) to rats is well known. In the present experiments male Wistar rats (100-150g) were injected in the tail vein with 0.5ml of 0.9% NaCl containing 200 units (0.5mg) of B-fructofuranosidase entrapped in rat erythrocytes. The animals were killed at intervals after injection and the enzyme activity in liver and spleen was assayed as described by Gregoriadis & Ryman (1972) . Fig. 1(A) shows theextensive localization of theentrapped enzyme in the liver and spleen 30min after injection. This level remained substantially unchanged after 24h. A crude subfractionation of liver showed most of the enzyme activity to be in the lysosomal-mitochondria1 fraction. Similar results have been reported with 8-glucuronidase entrapped in resealed mouse erythrocyte 'ghosts' when reinjected into other mice (Fiddler et al., 1974) .
The second method of demonstrating the uptake process was by the attachment of 99mTc to the resealed 'ghosts' in the presence of a SnCI, catalyst. The labelling procedure is well known for intact erythrocytes and the method is used clinically in spleen scanning (Hegde et al., 1973) . By using this method, the uptake of rat 99mTc-labelled resealed erythrocyte 'ghosts' into rat tissues was compared with that of 99mTc-labelled rat erythrocytes that had not been lysed and resealed. The efficiency of the labelling process was the same for resealed 'ghosts' and intact erythrocytes (60-70%). The results are summarized in Fig. 1 and represent the uptake 1 h after injection. It seems that the process of lysis and resealing damages the erythrocyte and it is thus rapidly removed from the circulation after reinjection (Fig. 1B) . The spleen is heavily implicated in this process, one of its functions being to remove damaged erythrocytes, but the liver still removes the greater part of the injected material. Injected 99mTc-labelled erythrocytes, which had not been subjected to lysis and resealing, are still almost exclusively found in the circulation 1 h after injection (Fig. 1C) . The use of the y emitter also enables the scanning of the injected animal by the use of a y camera, and visual evidence of the uptake can be obtained. The use of this method is already under investigation with 563rd MEETING. LONDON It seemed feasible that the condition of histiocytic medullary reticulosis in man, in which erythrocytes are taken up by the malignant cells, might also result in uptake of resealed erythrocyte 'ghosts' carrying suitable anti-cancer drugs. This could be investigated by the scanning procedure described above and if found to be the case, therapy could be attempted by the entrapment of suitable drugs in resealed 'ghosts'. To this end we have investigated the entrapment of adriamycin-DNA complexes (see Table 1 ) as this particular drug (adriamycin) could be used in such a therapy. Our preliminary results appear to show that much of the DNA of the complex is associated with, rather than entrapped in, the resealed erythrocytes. Although some of the drug has become dissociated from its carrier a considerable proportion remains attached and is associated with the resealed erythrocytes.
Heath et al. (1976) have shown that bovine serum albumin elicits an immune response when entrapped in liposomes and injected into CBA/lz mice, whereas the free protein gives no response. We have investigated the immune response in CBA@ mice to bovineserumalbuminentrapped inCBA/&erythrocyte 'ghosts' and found that a low response is produced.
In summary, it is apparent that the resealed erythrocyte 'ghost' may prove useful as a carrier of therapeutic agents, although at present its major use would be limited to conditions affecting the liver and spleen and possibly malignant diseases of the type mentioned. However, entrapment of materials in resealed 'ghosts' is very simple and little modification would be necessary to obtain asceptic preparations for reinjection. Indeed, erythrocytes could come from the patient to be treated. Finally, it may be possible, as indicated for liposomes (Gregoriadis, 1975) , that suitable surface modifications of the resealed 'ghost' might lead to a degree of target specificity for the vesicle carrier.
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